Switch View
© BusinessWire
24.10.2025
ISIN: US26622P1075
Doximity Inc
DOCS
LISTED
NYSE
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Doximity Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders.
If you currently own Doximity stock and acquired shares on or before June 24, 2021, you may be able to seek corporate governance reforms, the return of funds back to...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
Sobi showcases new data across rare inflammatory conditions at ACR 2025
News Preview
STOCKHOLM, Oct. 24, 2025 /PRNewswire/ -- Sobi® (STO: SOBI), a global biopharmaceutical company dedicated to delivering innovative treatments for patients with rare disease, will be presenting new data across its immunology portfolio at the annual American College of Rheumatology (ACR) Convergence 2025 meeting in...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Healthcare Reports Third Quarter 2025 Results
News Preview
HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2025.
Key third quarter metrics (all percentage changes compare 3Q 2025 to 3Q 2024 unless otherwise noted):
Revenues increased 9.6 percent to $19.161 billion
Net income attributable to HCA Healthcare, Inc. increased 29...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
24.10.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the enrollment of the first patient in its NANOCLAMP AF Study for the treatment of atrial fibrillation (AF). The successful first procedure was complete...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
24.10.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
News Preview
This trial is the first and largest study specifically designed to evaluate children and adolescents with severe alopecia areata, a population often underrepresented in clinical trials
New data show 71% of adolescents with severe disease treated with baricitini...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
News Preview
New long-term extension data show approximately 80% of patients achieved or maintained meaningful skin improvement (EASI 75) with EBGLYSS with half the doses compared to approved monthly maintenance dosing
Lilly submitted these data to the FDA for a potential l...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US31573L1052
FibroBiologics Inc.
FBLG
LISTED
NASDAQ
FibroBiologics to Present at Bio-Europe 2025
News Preview
HOUSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US22407B1089
Coya Therapeutics, Inc.
COYA
LISTED
NASDAQ
Coya Therapeutics Announces Pricing of $20 Million Upsized Public Offering of Common Stock
News Preview
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, today announced that it has priced an underwritten public offering of 3,636,364 shares of its common stock at a public...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US90184D1000
Twist Bioscience Corp
TWST
LISTED
NASDAQ
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders.
If you currently own Twist stock and acquired shares on or before December 20, 2018, you may be able to seek corporate governance reforms, the retur...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US9553061055
West Pharmaceutical Services Inc
WST
LISTED
NYSE
West to Participate in Upcoming Investor Conferences
News Preview
EXTON, Pa., Oct. 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences: ...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
Arcutis to Present New Quality of Life and Long-Term Data with ZORYVE® (roflumilast) Cream 0.15% and 0.05% for the Treatment of Atopic Dermatitis at the Fall Clinical Dermatology Conference
News Preview
WESTLAKE VILLAGE, Calif. and LAS VEGAS, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that new data demonstrating ZORYVE® (roflumilast) cream 0.15% and 0.05% improved quality of life, s...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US45826H1095
Integer Holdings Corp
ITGR
LISTED
NYSE
Payman Khales Assumes Role as Integer President and CEO
News Preview
~ Planned Leadership Transition Completed ~...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
24.10.2025
ISIN: US00773J2024
Spyre Therapeutics Inc
SYRE
LISTED
NASDAQ
Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025
News Preview
WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases, today announced scientific presentations at the ACR Convergenc...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio
News Preview
CAMBRIDGE, Mass. and CHICAGO, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Vanqua Bio today announced a license agreement granting Biogen exclusive worldwide rights to Vanqua’s preclinical, oral C5aR1 antagonist. This agreement strengthens Biogen’s immunology strategy by advancing a proven immune mechanism with the potential...
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Umplatzierung der Aktien von Bencis
News Preview
Pressemitteilung
Medios AG: Umplatzierung der Aktien von Bencis
Berlin, 24. Oktober 2025 – Die Medios-Gruppe („Medios“ oder „das Unternehmen“), ein führender Anbieter von Specialty Pharma in Europa, wurde darüber informiert, dass Bencis Capital Partners B.V. („Bencis“) ihren gesamten Aktienbesitz an der Medios AG umplatziert hat. Die Aktien, die ......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: DE000A1MMCC8
Medios AG
ILM1
LISTED
XETR
Reallocation of Bencis shares
News Preview
Press release
Medios AG: Block placement of Bencis shares
Berlin, October 24, 2025 – The Medios-Group (“Medios“ or “the Company”), a leading provider of Specialty Pharma in Europe, was informed that Bencis Capital Partners B.V. ("Bencis") has reallocated its entire shareholding in Medios AG. The shares, which represent a total of approx. 6.7% of ......
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US50127T1097
Kura Oncology Inc
KURA
LISTED
NASDAQ
Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin
News Preview
- Milestone triggered by dosing of first patient in frontline AML Phase 3 clinical program- ...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US7867001049
Sagimet Biosciences Inc
SGMT
LISTED
NASDAQ
Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference
News Preview
Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license partner Ascletis...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US61225M1027
Monte Rosa Therapeutics Inc
GLUE
LISTED
NASDAQ
Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-6160, a VAV1-directed Molecular Glue Degrader, to Treat Immune-mediated Diseases
News Preview
Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-6160...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: CA39342L1085
Green Thumb Industries Inc
GTII
LISTED
CSE
Green Thumb Industries to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
CHICAGO and VANCOUVER, British Columbia, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced it will release third quarter 2025 financial results after the market closes on Wednesday, Nove...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US00182C1036
ANI Pharmaceuticals Inc
ANIP
LISTED
NASDAQ
ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET
News Preview
PRINCETON, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its third quarter 2025 financial results on Friday, November 7, 2025, prior to the market open....
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: KYG4212K1040
Gushengtang Holdings Limited
2273
LISTED
HKSE
Gushengtang TCM and 1doc Form Strategic Partnership to Establish Singapore's Integrated TCM Service Model
News Preview
SINGAPORE, Oct. 24, 2025 /PRNewswire/ -- Gushengtang TCM officially launched its "Master TCM AI" system at GovWare 2025 on October 22. The launch coincides with a strategic partnership with 1doc and a signed agreement with August Global Partners (AGP) for strategic investment, supporting the shift toward evidence...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: US14843C1053
Castle Biosciences Inc
CSTL
LISTED
NASDAQ
New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference
News Preview
Castle is presenting data on DecisionDx®-Melanoma and its pipeline atopic dermatitis (AD) test at the 25th Annual Fall Clinical Dermatology Conference....
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: CH0038389992
BB Biotech AG
BION
LISTED
SIX
BB Biotech AG publishes its interim report
News Preview
Ad hoc announcement pursuant to Art. 53 LR
October 24, 2025
BB Biotech AG publishes its interim report
BB Biotech AG (ISIN CH0038389992) today published its interim report as at September 30, 2025, which covers the results of its business activities for the first nine months of 2025.
Based on the consolidated accounts of BB Biotech AG, net prof......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: CH0038389992
BB Biotech AG
BION
LISTED
SIX
BB Biotech AG veröffentlicht Zwischenbericht
News Preview
Ad hoc-Mitteilung gemäss Art. 53 KR
24. Oktober 2025BB Biotech AG veröffentlicht Zwischenbericht
Die BB Biotech AG (ISIN CH0038389992) hat heute den Zwischenbericht per 30. September 2025 veröffentlicht, welcher über die Ergebnisentwicklung für die ersten neun Monate 2025 informiert.
Basierend auf den konsolidierten Zahlen weist die BB Biotech A......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: CH0038389992
BB Biotech AG
BION
LISTED
SIX
Portfolio übertrifft Benchmark – erste Anzeichen einer Branchen-Erholung
News Preview
Medienmitteilung vom 24. Oktober 2025
BB Biotech Q3 2025: Portfolio übertrifft Benchmark – erste Anzeichen einer Branchen-Erholung
Aktienkurs: +20.0% in CHF / +20.1% in EUR / +19.5% in USD – deutlich besser als der Nasdaq Biotech Index (NBI), der um +15.6% in USD zulegte
NAV: +24.0% in CHF / +24.0% in EUR / +23.5% in USD – eine Outperformance v......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.10.2025
ISIN: CH0038389992
BB Biotech AG
BION
LISTED
SIX
Portfolio outperformance amid early signs of sector recovery
News Preview
Media release as at October 24, 2025
BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery
Share price: +20.0% in CHF / +20.1% in EUR / +19.5% in USD – notably outperforming the Nasdaq Biotech Index (NBI), which gained +15.6% in USD
NAV: +24.0% in CHF / +24.0% in EUR / +23.5% in USD – surpassing the benchmark NBI by 7......
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: KYG0330A1013
Alphamab Oncology
9966
LISTED
HKSE
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/αvβ6 Bispecfic ADC JSKN022
News Preview
SUZHOU, China, Oct. 24, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed at Sun Yat-sen University Cancer Center in the phase I clinical study (Study ID: JSKN022-101) of JSKN022, an independently developed innovative bispecific antibody-drug...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
49,164 Orion Corporation A shares converted into B shares
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 24 OCTOBER 2025 at 9.00 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press release: Q3: continued sales and earnings progress
News Preview
Q3: continued sales and earnings progress...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
ISIN: US37733W2044
GSK plc
GSK
LISTED
NYSE
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
News Preview
GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy, including a proteasome inhi...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: US2197981051
QuidelOrtho Corp
QDEL
LISTED
NASDAQ
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics
News Preview
SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 52 of its Science Bytes podcast, featuring George Wierschem, MBA, MT(ASCP), Senior Global Product Manager – Informatics....
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 23, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: CA53946V2066
Lobe Sciences Ltd.
LOBE
LISTED
CSE
Lobe Sciences Completes Debt Settlement to Improve Balance Sheet
News Preview
VANCOUVER, BC / ACCESS Newswire / October 23, 2025 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), operates as a pharmaceutical platform that develops novel therapies through a scalable model of shared services, global teams, and outsourced infrastructure. The Company creates intellectual prop...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US4500561067
iRhythm Technologies Inc
IRTC
LISTED
NASDAQ
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.
If you currently own iRhythm stock and acquired shares on or before November 5, 2021, you may be able to seek corporate governance reforms, the return...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US22407B1089
Coya Therapeutics, Inc.
COYA
LISTED
NASDAQ
Coya Therapeutics Announces Proposed Public Offering of Common Stock
News Preview
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The Co...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US89422G1076
Travere Therapeutics Inc
TVTX
LISTED
NASDAQ
Travere Therapeutics to Report Third Quarter 2025 Financial Results
News Preview
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2025 financial results on Thursday, October 30, 2025, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.
The webcast and dia...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US2036681086
Community Health Systems Inc
CYH
LISTED
NYSE
Community Health Systems, Inc. Announces Third Quarter Ended September 30, 2025 Results
News Preview
Community Health Systems, Inc. (NYSE: CYH) (the “Company”) today announced financial and operating results for the three and nine months ended September 30, 2025.
The following highlights the financial and operating results for the three months ended September 30, 2025.
Net operating revenues totaled $3.087 billion.
Net income attributable...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US2289031005
Artivion Inc
AORT
LISTED
NYSE
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results
News Preview
ATLANTA, Oct. 23, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the market closes. On that day, the Company will hold a tele...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US74587V1070
Puma Biotechnology Inc
PBYI
LISTED
NASDAQ
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
News Preview
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on Thursday, Nov. 6, 2025, following the release of its third quarter 2025 financial results.
The call may be accessed by dialing 1-877-709-8150 (domestic) or 1-201-689-8354 (international). Please dial in at least 10 mi...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US45773H4092
Inovio Pharmaceuticals Inc
INO
LISTED
NASDAQ
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
News Preview
PLYMOUTH MEETING, Pa., Oct. 23, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in a virtual fireside c...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US45720N1037
Inhibrx Biosciences Inc
INBX
LISTED
NASDAQ
Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
News Preview
Ozekibart meets its primary endpoint in chondrosarcoma, demonstrating a statistically significant and clinically meaningful improvement in median progression-free survival compared to placebo
Key secondary endpoints reinforce the primary benefit, demons...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US4576693075
Insmed Inc
INSM
LISTED
NASDAQ
Insmed Ranks No. 1 on Science's 2025 Top Biopharma Employers List
News Preview
—Insmed Leads Science Top Employers List for Fifth Year in a Row—
BRIDGEWATER, N.J., Oct. 23, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US14167L1035
CareDx Inc
CDNA
LISTED
NASDAQ
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
News Preview
CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the publication of the second study from Surveillance HeartCare Outcomes Registry (SHORE) in the Journ...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US7140461093
Revvity Inc
RVTY
LISTED
NYSE
Revvity Board Declares Quarterly Dividend
News Preview
The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on February 6, 2026 to all shareholders of record at the close of business on January 16, 2026.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to acti...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US09062W2044
BioLife Solutions Inc
BLFS
LISTED
NASDAQ
BioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025
News Preview
BOTHELL, Wash., Oct. 23, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the Company's third quarter 2025 financial results will be released after market close on Thur...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ: SMLR) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 23, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD).
IF YOU ARE AN INVE...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
News Preview
SAN DIEGO, Oct. 23, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the "Class Period"), have until Tuesday, December 2, 2025 to seek appointment as...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
News Preview
NEW YORK, Oct. 23, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US29772L1089
Eton Pharmaceuticals Inc
ETON
LISTED
NASDAQ
Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
News Preview
DEER PARK, Ill., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025. Management will...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Securities Fraud Investigation Into Baxter International, Inc. (BAX) Announced – Shareholders Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAX...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US2560861096
DocGo Inc
DCGO
LISTED
NASDAQ
Halper Sadeh LLC Encourages DocGo Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of DocGo Inc. (NASDAQ: DCGO) breached their fiduciary duties to shareholders.
If you currently own DocGo stock and acquired shares on or before November 5, 2021, you may be able to seek corporate governance reforms, the return of funds back to...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US05380C1027
AVITA Medical Inc
RCEL
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
News Preview
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ("Avita" or the "Company") (NASDAQ: RCEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis ranked #2 Top Employer by Science magazine, recognizing industry-leading scientific innovation and company culture
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the company was named as a top employer to work for by Science magazine in its annual Top Employer survey of the biopharmaceutical and related industries. In its first year of eligibility for the award, Ionis was ranked second based on industry-leading innovation, strong alignment of compa...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US24477E1038
Definitive Healthcare Corp
DH
LISTED
NASDAQ
Definitive Healthcare Announces Timing of Its Third Quarter 2025 Financial Results Conference Call and Webcast
News Preview
FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025 after market close. The company will...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US87918A1051
Teladoc Health Inc
TDOC
LISTED
NYSE
Teladoc Health Announces Chief Financial Officer Transition
News Preview
Provides Preliminary Third Quarter 2025 Consolidated Financial Results, Reaffirms Full-Year 2025 Consolidated Outlook Provides Preliminary Third Quarter 2025 Consolidated Financial Results, Reaffirms Full-Year 2025 Consolidated Outlook...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US89455T1097
Treace Medical Concepts Inc
TMCI
LISTED
NASDAQ
Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
PONTE VEDRA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the third quarter 2025 after the...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US1717571079
Cidara Therapeutics, Inc.
CDTX
LISTED
NASDAQ
Cidara Therapeutics to Report Third Quarter 2025 Financial Results and Host Quarterly Conference Call on November 6, 2025
News Preview
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that it will report its third quarter 2025 financial results and operational highlights after the close of the U.S. financial...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: US82657M1053
Sight Sciences Inc
SGHT
LISTED
NASDAQ
Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
MENLO PARK, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced it will report financial results for the...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
